Details for New Drug Application (NDA): 022173
✉ Email this page to a colleague
NDA 022173 describes ZYPREXA RELPREVV, which is a drug marketed by Cheplapharm and is included in one NDA. It is available from two suppliers. Additional details are available on the ZYPREXA RELPREVV profile page.
The generic ingredient in ZYPREXA RELPREVV is olanzapine pamoate. There are thirty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the olanzapine pamoate profile page.
The generic ingredient in ZYPREXA RELPREVV is olanzapine pamoate. There are thirty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the olanzapine pamoate profile page.
Summary for 022173
| Tradename: | ZYPREXA RELPREVV |
| Applicant: | Cheplapharm |
| Ingredient: | olanzapine pamoate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 022173
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173 | NDA | Eli Lilly and Company | 0002-7635 | 0002-7635-11 | 1 KIT in 1 CARTON (0002-7635-11) * 1.4 mL in 1 VIAL (0002-7658-01) * 3 mL in 1 VIAL (0002-7622-01) |
| ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173 | NDA | Eli Lilly and Company | 0002-7636 | 0002-7636-11 | 1 KIT in 1 CARTON (0002-7636-11) * 2 mL in 1 VIAL (0002-7659-01) * 3 mL in 1 VIAL (0002-7622-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | EQ 210MG BASE/VIAL | ||||
| Approval Date: | Dec 11, 2009 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | EQ 300MG BASE/VIAL | ||||
| Approval Date: | Dec 11, 2009 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | EQ 405MG BASE/VIAL | ||||
| Approval Date: | Dec 11, 2009 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 022173
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
